Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)

The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis when sold at a concentration equal to or greater than 1 mg/ml (1:1000) to the Prescription Drug List (PDL). Both the Human and the Veterinary parts of the PDL were revised.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-10-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data